PuraPharm Corporation Limited announced that the annual general meeting was held on 28 May 2021 (the AGM). Upon the conclusion of the AGM: Dr. Tsoi Kam Biu, Alvin ("Dr. Tsoi") has retired as an executive Director and a member of the remuneration committee of the Board (the "Remuneration Committee"); Mr. Chan Kin Man, Eddie ("Mr. Chan") has retired as a non-executive Director; and Dr. Chan Kin Keung, Eugene ("Dr. Chan") has retired as an independent non-executive Director and the chairman of the Remuneration Committee and a member of the audit committee of the Board (the "Audit Committee"). Following the retirement of Dr. Tsoi as the executive Director, Dr. Tsoi is appointed as the senior adviser of the Company. Following the conclusion of the AGM, the Board resolved that to adopt the following changes to the composition of the Board committees with immediate effect: Professor Tsui Lap Chee is appointed as a member of the Audit Committee; Dr. Leung Lim Kin, Simon ceases to be a member of the Nomination Committee and is appointed as the chairman of the Remuneration Committee; Mr. Chow, Stanley is appointed as a member of the Remuneration Committee; and Mr. Ho Kwok Wah, George is appointed as a member of the Nomination Committee.